JPY 4088.0
(-0.58%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 60.04 Billion | 47.23 Billion | 28.83 Billion | 9.28 Billion | 51.48 Billion | 45.85 Billion |
Net Income | 87.65 Billion | 32.85 Billion | -2.89 Billion | -32.33 Billion | 40.95 Billion | 50.56 Billion |
Depreciation & Amortization | 33.35 Billion | 31.61 Billion | 30.48 Billion | 30.24 Billion | 29.08 Billion | 25.6 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -49 Million | -406 Million | 1.46 Billion | -618 Million | 537 Million | -1.27 Billion |
Other non-cash items | 7.93 Billion | -16.83 Billion | -222 Million | 11.99 Billion | -19.09 Billion | -29.03 Billion |
Investing Cash Flow | 28.13 Billion | -29.5 Billion | -33.76 Billion | -28.67 Billion | -48.07 Billion | -53.43 Billion |
Investments in PPE | -54.53 Billion | -32.83 Billion | -38.23 Billion | -33.34 Billion | -47.3 Billion | -53.51 Billion |
Acquisitions | 81 Billion | 850 Million | 98 Million | -56 Million | -3.03 Billion | 53.51 Billion |
Investment purchases | -3.33 Billion | -850 Million | -98 Million | -263 Million | -1.17 Billion | -4.11 Billion |
Sales/Maturities of investments | - | 256 Million | 1.41 Billion | 33.34 Billion | 47.3 Billion | 1.22 Billion |
Other Investing Activities | 5 Billion | 3.07 Billion | 3.05 Billion | -28.35 Billion | -43.86 Billion | -50.53 Billion |
Financing Cash Flow | -40.26 Billion | -20.91 Billion | 1.23 Billion | 21.49 Billion | -4.41 Billion | 7.24 Billion |
Debt repayment | -479 Million | -15.69 Billion | -10.08 Billion | -20.78 Billion | -30.69 Billion | -18.76 Billion |
Dividends payments | -4.13 Billion | -2.88 Billion | -2.9 Billion | -2.9 Billion | -3.08 Billion | -2.66 Billion |
Common Stock Repurchased | -31.6 Billion | -23.66 Billion | - | - | - | - |
Common Stock Issuance | - | 24.69 Billion | - | - | - | - |
Other Financing Activities | -4.04 Billion | -3.37 Billion | 14.22 Billion | 45.18 Billion | 29.36 Billion | 28.66 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | -2.14 Billion | -406 Million | 1.46 Billion | -618 Million | 537 Million | -1.27 Billion |
Other working capital | 2.09 Billion | 7.31 Billion | -514 Million | -2.35 Billion | 1.61 Billion | -1.8 Billion |
Cash at beginning of period | 34.41 Billion | 25.27 Billion | 28.9 Billion | 26.67 Billion | 25.01 Billion | 24.41 Billion |
Cash at end of period | 82.32 Billion | 34.41 Billion | 25.27 Billion | 28.9 Billion | 26.67 Billion | 25.01 Billion |
Capital Expenditure | -54.53 Billion | -32.83 Billion | -38.23 Billion | -33.34 Billion | -47.3 Billion | -53.51 Billion |
Effect of forex changes on cash | - | 12.31 Billion | 74 Million | 123 Million | 2.65 Billion | 934 Million |
Net cash flow / Change in cash | 47.91 Billion | 9.13 Billion | -3.62 Billion | 2.22 Billion | 1.65 Billion | 601 Million |
Free Cash Flow | 5.51 Billion | 14.4 Billion | -9.4 Billion | -24.06 Billion | 4.18 Billion | -7.66 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 13.31 Billion | 51.66 Billion | 87.65 Billion | 14.89 Billion | 10.47 Billion | 10.62 Billion |
Depreciation & Amortization | - | - | 33.35 Billion | 8.4 Billion | 8.27 Billion | 8.12 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -49 Million | - | - | - |
Other non-cash items | -13.31 Billion | -51.66 Billion | 7.93 Billion | -14.89 Billion | -10.47 Billion | -10.62 Billion |
Investing Cash Flow | - | - | 28.13 Billion | - | - | - |
Investments in PPE | - | - | -54.53 Billion | - | - | - |
Acquisitions | - | - | 81 Billion | - | - | - |
Investment purchases | - | - | -3.33 Billion | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 5 Billion | - | - | - |
Financing Cash Flow | - | - | -40.26 Billion | - | - | - |
Debt repayment | - | - | -479 Million | - | - | - |
Dividends payments | - | - | -4.13 Billion | - | - | - |
Common Stock Repurchased | - | - | -31.6 Billion | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -4.04 Billion | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | -2.14 Billion | - | - | - |
Other working capital | - | - | 2.09 Billion | - | - | - |
Cash at beginning of period | - | - | 34.41 Billion | 41.19 Billion | 47.08 Billion | 34.41 Billion |
Cash at end of period | - | - | 82.32 Billion | 46.08 Billion | 41.19 Billion | 47.08 Billion |
Capital Expenditure | - | - | -54.53 Billion | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 47.91 Billion | 4.88 Billion | -5.88 Billion | 12.67 Billion |
Free Cash Flow | - | - | 5.51 Billion | 16.81 Billion | 16.55 Billion | 16.24 Billion |
601828
300847
UBEOF
ZYME
LPRO
IGCIL